Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting redox-active pyridinium cations to mitochondria to inhibit proliferation of drug-resistant cancer cells

Targeting redox-active pyridinium cations to mitochondria to inhibit proliferation of drug-resistant cancer cells

US Patent 12358935 · Granted Jul 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mito-honokiol compounds and methods of synthesis and use thereof2024
Mito-honokiol compounds and methods of synthesis and use thereof2024
Mito-magnolol compounds and methods of synthesis and use thereof2023
Mito-magnolol compounds and methods of synthesis and use thereof2023
Mito-lonidamine, compositions and methods of use2022
Modified mito-metformin compounds and methods of synthesis and use thereof2022
Mito-magnolol compounds and methods of synthesis and use thereof2021
Mito-magnolol compounds and methods of synthesis and use thereof2021
Mito-honokiol compounds and methods of synthesis and use thereof2020
Mito-honokiol compounds and methods of synthesis and use thereof2020
Neuroprotection by mitochondria-targeted metformin2020
Neuroprotection by mitochondria-targeted metformin2018